Variant report
Variant | rs56826756 |
---|---|
Chromosome Location | chr2:113696988-113696989 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113694000-113699200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr2:113695800-113697600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr2:113696000-113697400 | Enhancers | HMEC | breast |
4 | chr2:113696200-113697000 | Flanking Active TSS | Liver | Liver |
5 | chr2:113696400-113697200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr2:113696400-113697600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr2:113696600-113697000 | Enhancers | NH-A | brain |
8 | chr2:113696600-113697000 | Enhancers | NHEK | skin |
9 | chr2:113696600-113697000 | Enhancers | Osteobl | bone |
10 | chr2:113696600-113697200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr2:113696600-113697400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr2:113696600-113697400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr2:113696800-113697200 | Weak transcription | Gastric | stomach |
14 | chr2:113696800-113697400 | Bivalent Enhancer | HepG2 | liver |